Education
About Us
Working with TipRanks
Follow Us
Masaru Matsuda Insider Profile
4 Followers
Masaru Matsuda, SVP & GC at Halozyme, holds 151.48K shares in Arcutis Biotherapeutics (Ticker: ARQT), holds 20.05K shares in Halozyme (Ticker: HALO). Most recently, Masaru Matsuda Sold ― shares of Arcutis Biotherapeutics on Nov 21, 2025 for an estimated value of $72.13K.
Profitable Transactions
2 out of 11 Profitable Transactions
Average Return
-81.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Masaru Matsuda holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Nov 22, 2022 - Nov 22, 2023
Return:+89.70%
The most profitable trade made by Masaru Matsuda
Masaru Matsuda's Trading History
Halozyme
Sep 07, 2021
SVP & GC
Uninformative Buy
146.55K
$1.46M
Arcutis Biotherapeutics
Nov 21, 2025
Reporting Person's title: SVP GC and Corporate Secretary
Informative Sell
72.13K
$4.69M
List of latest transactions for each holding click on a transaction to see Masaru Matsuda's performance on stock
You May Also Like
Masaru Matsuda insider profile FAQ
What is the percentage of profitable transactions made by Masaru Matsuda?
The percentage of profitable transactions made by Masaru Matsuda is 18%.
What is the average return per transaction made by Masaru Matsuda?
The average return per transaction made by Masaru Matsuda is -81.50%.
What stocks does Masaru Matsuda hold?
Masaru Matsuda holds: HALO, ARQT stocks.
What was Masaru Matsuda’s latest transaction?
Masaru Matsuda latest transaction was an Informative Sell of $72.13K.
What was Masaru Matsuda's most profitable transaction?
Masaru Matsuda’s most profitable transaction was an Informative Sell of ARQT stock on November 22, 2022. The return on the trade was 89.70%.
What is Masaru Matsuda's role in Halozyme?
Masaru Matsuda's role in Halozyme is SVP & GC.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.